FlexiProject is pharma project management software that keeps R&D, clinical trials, regulatory submissions and launches moving together, from early pipeline decisions all the way to market.
Trusted by
Manage the full timeline of a study or a launch in one place, from protocol and site setup to database lock, submission and approval. Milestones are marked as fixed dates, so when one activity slips you see the knock-on effect on everything downstream and can rebook people and vendors before the deadline is genuinely at risk.
Turn recurring project types, a Phase II trial, a tech transfer, a process validation, a submission, into templates that already carry the right stage-gate structure, tasks and documents. Every new program starts from a plan that passed audit before, so teams spend time on the science, not on rebuilding the same schedule from scratch.
Define what each project actually has to produce, a dossier, a batch record, a validation report, a submission package, and track it as a named product with its own acceptance. Nothing counts as done until the deliverable that regulators and QA will scrutinise genuinely exists and has been signed off, not simply because a task was closed.
Bring R&D, clinical, capital and lifecycle work into separate portfolios, each with the right horizon and its own reviews. A dedicated stage-gate R&D portfolio can sit next to a CAPEX portfolio with multi-year ROI, and management sees status, cost and risk across all of them in real time, instead of piecing it together from spreadsheets.
Run portfolio reviews on a fixed cadence instead of only when something breaks. At each review, management sees current progress, cost and risk for every program in one place and makes go, no-go and reprioritise calls on live data, so the stage-gate decisions that steer the pipeline happen on schedule rather than months too late.
Run every molecule, formulation and device program through one repeatable, stage-gated process, from discovery and preclinical to the clinical phases and submission, with the whole team working to the same plan.
Explore innovation and R&D projects
Manage plant expansions, line qualifications and lab fit-outs with the same discipline as an R&D program, so the capital projects that keep manufacturing compliant never slip through the cracks.
Explore recurring projects
Scientists and project leads work from one shared schedule, see how each activity depends on the next, and know what is blocking the next milestone before a submission date is at risk.
Explore management board
The PMO gets one view of every program in the pipeline, with status, cost and risk in real time, and steers the whole portfolio of studies and investments from a single place.
Explore PMO software
See how FlexiProject helps pharma and biotech teams plan, prioritize and deliver R&D and investment projects. Start a 30-day trial or talk to our team.
Syvento is a biotech CDMO specializing in mRNA and lipid nanoparticle formulations. We focus on the development and manufacturing of mRNA and advanced lipid nanocarriers at our state-of-the-art, GMP-certified production facility.
Learn more
Mabion is a European biotechnology company developing drugs of the recombinant protein class, including monoclonal antibodies and vaccines. It is a forerunner in the biotechnology sector in Central Europe. Mabion specializes in manufacturing sterile…
Learn more
PBKM is the largest stem cell bank in Poland and Europe. It provides access to innovative treatments from harvested stem cells and saves the lives and health of children, as well as other family…
Learn more
The Europlant Group develops and produces effective and safe liquid herbal medicines and medicinal teas based on active ingredients of the highest quality. Europlant operates a distribution network of products through pharmacies in Central…
Learn moreScope, objectives, milestones, budget and the people accountable for a trial or a launch live in a single project charter that everyone approves before work starts. When regulatory or clinical priorities shift, you update the charter once and the whole team keeps working from the same current definition, not last quarter’s assumptions.
Turn live pipeline data into clear reports for the board, an inspection or a development partner: progress, cost, risk and milestones across every program, built once and always current. When leadership asks which trials with a gate this quarter are slipping, the answer is a click away instead of a day of exports from separate systems.
Bring pipeline, schedule and risk together on your own programs. Start a 30-day trial or talk to our team.
Explore how FlexiProject helps organizations with similar project management challenges achieve better results.
The best pharma project management software is a system built for the way drugs and devices are actually developed: stage-gated R&D, long clinical timelines, strict regulatory milestones and portfolios that compete for scarce scientists and budget. FlexiProject covers this end to end, combining phase-gate approvals, objective project scoring, milestone scheduling, risk tracking and portfolio oversight in one place. It is aimed at PMOs and R&D leaders in larger pharma and biotech organizations, not at ad hoc task lists.
Yes. A trial or a submission is planned as a project with its own schedule, milestones, owners and risks, from protocol and site setup through database lock to filing and approval. Fixed-date milestones make dependencies explicit, so when one activity slips you can see the effect on the submission date and rebook people and vendors early. Documents and evidence tied to each phase gate stay recorded, which helps when an audit or an inspection asks how a decision was made.
FlexiProject uses project approval paths to enforce a stage-gate process: each phase must pass a defined review before the next one is funded and started. Approvers assess a candidate against the evidence and the project’s score, and every go, hold or kill decision is captured with its rationale. Because scoring and approvals sit next to the portfolio view, leadership can compare programs on the same criteria and stop funding the ones that no longer earn their place.
Yes. FlexiProject is used by regulated organizations and offers the same functionality in the cloud (SaaS) or on-premise, so companies with strict data policies keep full control of their infrastructure without giving up features. Roles, permissions and an audit-friendly history of changes and approvals support the governance that pharma and biotech require. Templates keep every project running to the same documented process, which makes internal and external audits far easier to satisfy.
The FlexiProject interface is available in 28 languages, with user documentation in 11 languages, which suits pharma and biotech groups that run programs across several countries and sites. A companion mobile app lets team members view assigned tasks, change their status, and add comments and attachments such as photos and documents, so progress can be updated from the lab, the plant floor or on the move. The browser version remains the full working environment for planning and reporting.
If you want to see how FlexiProject fits your pharma and biotech projects, feel free to talk to our specialists.
